Pfizer to Appeal India Decision to Revoke Cancer Drug Patent
Pfizer, the India unit of U.S. drugmaker Pfizer, will challenge the country’s patent office for revoking a patent for its cancer drug Sutent (sunitinib).
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.